Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.
Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.
Global Markets Direct
 

List of reports from Global Markets Direct

1  2    4    6  7  8  9  10  
Oasmia Pharmaceutical AB - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Oasmia Pharmaceutical AB’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
$1,500.00
Advanced Accelerator Applications - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Advanced Accelerator Applications’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
$1,500.00
Natco Pharma Limited - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Natco Pharma Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
$1,500.00
Laboratorios LETI S.L. - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios LETI S.L.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
$1,500.00
Apceth GmbH & Co. KG - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... Co. KG’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Apceth GmbH & Co. KG’s, complete with comparative analysis at various stages, therapeutics assessment by drug ...  |  read more...
$1,500.00
Orexo AB - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Orexo AB’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
$1,500.00
ImmunGene, Inc. - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of ImmunGene, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
$1,500.00
Istituto Italiano di Tecnologia - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Istituto Italiano di Tecnologia’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
$1,500.00
Orphazyme ApS - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Orphazyme ApS’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
$1,500.00
Wroclawskie Centrum Badan EIT+ Sp. z o.o. - Product Pipeline Review - 2014
3/31/2014 | published by: Global Markets Direct
... the Wroclawskie Centrum Badan EIT+ Sp. z o.o.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Wroclawskie Centrum Badan EIT+ Sp. z o.o.’s, complete with comparative ...  |  read more...
$1,500.00
Duchenne Muscular Dystrophy - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Duchenne Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Diffuse Large B-Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Migraine - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Migraine, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
$2,000.00
Bladder Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Bladder Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Osteoarthritis Pain - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Osteoarthritis Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Cytomegalovirus (HHV-5) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Major Depressive Disorder - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Major Depressive Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with comparative analysis at various ...  |  read more...
$2,000.00
Refractory Multiple Myeloma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Refractory Multiple Myeloma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Mantle Cell Lymphoma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Mantle Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for B-Cell Non-Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Drug Addiction - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Drug Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Hodgkin Lymphoma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Peritoneal Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Peritoneal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Metastatic Renal Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
1  2    4    6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!